MK-0533

CAS No. 668455-28-5

MK-0533( —— )

Catalog No. M36129 CAS No. 668455-28-5

MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 237 Get Quote
5MG 366 Get Quote
10MG 543 Get Quote
25MG 845 Get Quote
50MG 1150 Get Quote
100MG 1521 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-0533
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • Description
    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    668455-28-5
  • Formula Weight
    527.49
  • Molecular Formula
    C28H24F3NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC=1N(C=2C(C1C(=O)C3=CC=C(OC)C=C3)=CC=C(OC(F)(F)F)C2)C4=CC(O[C@@H](C(O)=O)CC)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ankaflavin

    Ankaflavin, isolated from Monascus-Fermented red rice, is a PPARγ agonist with anti-inlfammatory activity.

  • (R)-(+)-Bay-K-8644

    (R)-(+)-Bay-K-8644 is a Ca2+ channel and dihydropyridine agonist that inhibits Ba2+ currents (IBa), induces central respiratory depression in cats, and inhibits platelet activation through competitive antagonism of thromboxane A2-prostaglandin H2 receptors.

  • CGS 15435

    CGS 15435 is a potent thromboxen (TxA2) synthetase inhibitor (IC50: 1 nM). CGS 15435 acts on PGI2 synthase, cyclooxygenase and liposynthase with much less selectivity than on thromboxin synthase.